SCHEMBL21882053

SCHEMBL21882053

CP(C)(=O)c1cccc(-c2ccc(-c3c4ccc5ccccc5c4nc4c3ccc3ccccc34)cc2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ESR1 P03372 5/20 0.36
ESR2 Q92731 4/20 0.35
MAOA P21397 1/20 0.35
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
CYP1A1 P04798 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP1B1 Q16678 2/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
ACP3 P15309 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
HSD17B1 P14061 1/20 0.32
CYP2B6 P20813 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21881882 0.94 MAPT (0.38) MAPTL3MBTL1ESR1ESR2MAOA
SCHEMBL18892984 0.93 MAPT (0.39) MAPTL3MBTL1ESR1ESR2MAOA
SCHEMBL18904710 0.92 HSD17B1 (0.34) MAPTL3MBTL1ESR1ESR2MAOA
SCHEMBL18892980 0.90 MAPT (0.37) MAPTL3MBTL1ESR1ESR2MAOA
SCHEMBL18892986 0.88 MAPT (0.38) MAPTL3MBTL1ESR1ESR2MAOA
SCHEMBL21881883 0.86 MAPT (0.39) MAPTL3MBTL1ESR1ESR2MAOA
SCHEMBL21922947 0.86 MAOA (0.36) MAPTL3MBTL1ESR1ESR2MAOA
SCHEMBL18892965 0.86 MAOA (0.42) MAPTL3MBTL1ESR1ESR2MAOA
SCHEMBL20761577 0.85 ESR1 (0.36) MAPTL3MBTL1ESR1ESR2MAOA
SCHEMBL21922888 0.85 MAOA (0.37) MAPTL3MBTL1ESR1ESR2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 MAPT 4555/4885L3MBTL1 812/4885ESR1 17/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 MAPT 4555/4885L3MBTL1 812/4885ESR1 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.